Header Logo

Connection

Douglas Corley to Case-Control Studies

Back to Details
This is a "connection" page, showing publications Douglas Corley has written about Case-Control Studies.
Douglas Corley
Connection Strength
3.067
Case-Control Studies
  1. Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population. Am J Gastroenterol. 2020 05; 115(5):706-715.
    View in: PubMed
    Score: 0.143
  2. Validation of an Algorithm to Identify Patients at Risk for Colorectal Cancer Based on Laboratory Test and Demographic Data in Diverse, Community-Based Population. Clin Gastroenterol Hepatol. 2020 11; 18(12):2734-2741.e6.
    View in: PubMed
    Score: 0.143
  3. Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers. Gastrointest Endosc. 2019 01; 89(1):168-176.e3.
    View in: PubMed
    Score: 0.127
  4. Proton Pump Inhibitor and Histamine-2 Receptor Antagonist Use and Iron Deficiency. Gastroenterology. 2017 03; 152(4):821-829.e1.
    View in: PubMed
    Score: 0.113
  5. Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus. Am J Gastroenterol. 2016 11; 111(11):1528-1535.
    View in: PubMed
    Score: 0.111
  6. Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett's Esophagus. Dig Dis Sci. 2016 Jan; 61(1):70-9.
    View in: PubMed
    Score: 0.104
  7. Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease. Clin Gastroenterol Hepatol. 2015 Dec; 13(13):2256-64.e1-3.
    View in: PubMed
    Score: 0.099
  8. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of Barrett's esophagus. Dig Dis Sci. 2015 Feb; 60(2):436-43.
    View in: PubMed
    Score: 0.097
  9. Dietary guideline adherence for gastroesophageal reflux disease. BMC Gastroenterol. 2014 Aug 14; 14:144.
    View in: PubMed
    Score: 0.096
  10. Alcohol and the risk of Barrett's esophagus: a pooled analysis from the International BEACON Consortium. Am J Gastroenterol. 2014 Oct; 109(10):1586-94.
    View in: PubMed
    Score: 0.096
  11. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013 Dec 11; 310(22):2435-42.
    View in: PubMed
    Score: 0.092
  12. Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas. Gastroenterology. 2013 Aug; 145(2):312-9.e1.
    View in: PubMed
    Score: 0.088
  13. Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium. Gut. 2013 Dec; 62(12):1684-91.
    View in: PubMed
    Score: 0.087
  14. Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Gastroenterology. 2012 Apr; 142(4):744-53.
    View in: PubMed
    Score: 0.081
  15. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology. 2010 Jul; 139(1):93-101.
    View in: PubMed
    Score: 0.071
  16. Effects of dietary fiber, fats, and meat intakes on the risk of Barrett's esophagus. Nutr Cancer. 2009; 61(5):607-16.
    View in: PubMed
    Score: 0.065
  17. Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus. Gastroenterology. 2009 Mar; 136(3):806-15.
    View in: PubMed
    Score: 0.065
  18. Cigarette smoking and the risk of Barrett's esophagus. Cancer Causes Control. 2009 Apr; 20(3):303-11.
    View in: PubMed
    Score: 0.064
  19. Iron intake and body iron stores as risk factors for Barrett's esophagus: a community-based study. Am J Gastroenterol. 2008 Dec; 103(12):2997-3004.
    View in: PubMed
    Score: 0.064
  20. Helicobacter pylori and gastroesophageal reflux disease: a case-control study. Helicobacter. 2008 Oct; 13(5):352-60.
    View in: PubMed
    Score: 0.064
  21. Dietary antioxidants, fruits, and vegetables and the risk of Barrett's esophagus. Am J Gastroenterol. 2008 Jul; 103(7):1614-23; quiz 1624.
    View in: PubMed
    Score: 0.063
  22. Hemochromatosis gene status as a risk factor for Barrett's esophagus. Dig Dis Sci. 2008 Dec; 53(12):3095-102.
    View in: PubMed
    Score: 0.062
  23. Dietary patterns and the risk of Barrett's esophagus. Am J Epidemiol. 2008 Apr 01; 167(7):839-46.
    View in: PubMed
    Score: 0.061
  24. Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut. 2008 Jun; 57(6):727-33.
    View in: PubMed
    Score: 0.060
  25. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology. 2007 Oct; 133(4):1106-12.
    View in: PubMed
    Score: 0.059
  26. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007 Jul; 133(1):34-41; quiz 311.
    View in: PubMed
    Score: 0.058
  27. Barrett's esophagus and medications that relax the lower esophageal sphincter. Am J Gastroenterol. 2006 May; 101(5):937-44.
    View in: PubMed
    Score: 0.054
  28. Fecal Immunochemical Test Screening and Risk of Colorectal Cancer Death. JAMA Netw Open. 2024 Jul 01; 7(7):e2423671.
    View in: PubMed
    Score: 0.048
  29. Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterology. 2020 12; 159(6):2065-2076.e1.
    View in: PubMed
    Score: 0.037
  30. Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts. Nat Commun. 2020 09 04; 11(1):4423.
    View in: PubMed
    Score: 0.037
  31. The effect of using fecal testing after a negative sigmoidoscopy on the risk of death from colorectal cancer. J Med Screen. 2021 06; 28(2):140-147.
    View in: PubMed
    Score: 0.036
  32. Cumulative Burden of Colorectal Cancer-Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer. Gastroenterology. 2020 04; 158(5):1274-1286.e12.
    View in: PubMed
    Score: 0.035
  33. Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations. Cancer Causes Control. 2020 Jan; 31(1):85-93.
    View in: PubMed
    Score: 0.035
  34. Diabetes in relation to Barrett's esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett's and Esophageal Adenocarcinoma Consortium. Cancer. 2019 12 01; 125(23):4210-4223.
    View in: PubMed
    Score: 0.034
  35. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants. Gastroenterology. 2018 04; 154(5):1273-1281.e3.
    View in: PubMed
    Score: 0.030
  36. Dietary sugar/starches intake and Barrett's esophagus: a pooled analysis. Eur J Epidemiol. 2017 11; 32(11):1007-1017.
    View in: PubMed
    Score: 0.030
  37. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut. 2018 02; 67(2):291-298.
    View in: PubMed
    Score: 0.028
  38. Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis. Clin Gastroenterol Hepatol. 2016 10; 14(10):1412-1419.e3.
    View in: PubMed
    Score: 0.027
  39. Racial disparities in renal cell carcinoma: a single-payer healthcare experience. Cancer Med. 2016 08; 5(8):2101-8.
    View in: PubMed
    Score: 0.027
  40. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus. Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11):1739-47.
    View in: PubMed
    Score: 0.026
  41. Observational methods to assess the effectiveness of screening colonoscopy in reducing right colon cancer mortality risk: SCOLAR. J Comp Eff Res. 2015 Nov; 4(6):541-51.
    View in: PubMed
    Score: 0.026
  42. MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium. PLoS One. 2015; 10(6):e0128617.
    View in: PubMed
    Score: 0.025
  43. Chronic kidney disease and risk of renal cell carcinoma: differences by race. Epidemiology. 2015 Jan; 26(1):59-67.
    View in: PubMed
    Score: 0.025
  44. Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma. Carcinogenesis. 2014 Dec; 35(12):2740-7.
    View in: PubMed
    Score: 0.024
  45. Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON). PLoS One. 2014; 9(7):e103508.
    View in: PubMed
    Score: 0.024
  46. Approaches for classifying the indications for colonoscopy using detailed clinical data. BMC Cancer. 2014 Feb 15; 14:95.
    View in: PubMed
    Score: 0.023
  47. Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. J Natl Cancer Inst. 2013 Nov 20; 105(22):1711-8.
    View in: PubMed
    Score: 0.023
  48. A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet. 2013 Dec; 45(12):1487-93.
    View in: PubMed
    Score: 0.023
  49. Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013 May; 37(10):953-62.
    View in: PubMed
    Score: 0.022
  50. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):312-20.
    View in: PubMed
    Score: 0.022
  51. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet. 2012 Oct; 44(10):1131-6.
    View in: PubMed
    Score: 0.021
  52. The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium. Cancer Epidemiol. 2012 Jun; 36(3):306-16.
    View in: PubMed
    Score: 0.020
  53. Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis. Gastroenterology. 2012 Mar; 142(3):442-452.e5; quiz e22-3.
    View in: PubMed
    Score: 0.020
  54. Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol. 2011 Nov; 106(11):1911-21; quiz 1922.
    View in: PubMed
    Score: 0.020
  55. Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. Eur J Cancer. 2010 Jul; 46(11):2067-76.
    View in: PubMed
    Score: 0.018
  56. Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis. 2005 Mar 01; 191(5):761-7.
    View in: PubMed
    Score: 0.012

© 2024 Kaiser Permanente